Skip to content

Released Aug 7, 2018, after the close

10-Q filed Aug 8, 2018, 39 days after period end · 0001162194-18-000089

Q2 2018 · 10-Q
Revenue$26.43M+10.5% vs Q2 2017+4.7% vs Q1 2018
Net Income-$16.24MN/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.42N/M vs Q2 2017N/M vs Q1 2018
Gross Profit$13,588,000—
Operating Income-$12,785,000N/M
Operating Cash Flowderived-$4,323,000N/M
Free Cash Flowderived-$4,400,000N/M
Margins · derived
Gross margin51.4%
Operating margin-48.4%+20.6 pt vs Q2 2017
Net margin-61.5%+9.4 pt vs Q2 2017

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2018Q2 2017Q2 2016Q2 2015
Revenue$26.43M$23.91M$28.17M$28.62M
Net Income-$16.24M-$16.93M-$18.62M-$15.24M
EPS Diluted-$0.42-$0.58-$0.64-$0.53

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR